CoChat

Prevalence and Correlates of Patient Rationing of Insulin in the United States: A National Survey

Gaffney, Adam, Himmelstein, David U., Woolhandler, Steffie · 2022 · Annals of Internal Medicine
Cited by 47

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Letters18 October 2022Prevalence and Correlates of Patient Rationing of Insulin in the United States: A National SurveyAdam Gaffney, MD, MPH, David U. Himmelstein, MD, Steffie Woolhandler, MD, MPHAdam Gaffney, MD, MPHDepartment of Medicine, Cambridge Health Alliance, and Harvard Medical School, Cambridge, Massachusetts, David U. Himmelstein, MDHunter College, City University of New York, Department of Medicine, Cambridge Health Alliance, Harvard Medical School, and Public Citizen Health Research Group, New York, New York, Steffie Woolhandler, MD, MPHHunter College, City University of New York, Department of Medicine, Cambridge Health Alliance, Harvard Medical School, and Public Citizen Health Research Group, New York, New YorkAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M22-2477 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Background: Insulin is life saving for many patients with diabetes, but high prices and inadequate insurance coverage may impede access to it. A single-center study (1) and web-based surveys (2) suggest that cost-related insulin nonadherence may be common, although reliable national data are lacking.Objective: To determine the prevalence and correlates of insulin rationing.Methods: We analyzed the 2021 National Health Interview Survey (NHIS) done by the Centers for Disease Control and Prevention, which collected data for 1 randomly selected adult in a nationally representative sample of U.S. households (response rate = 52.8%). We assessed all adults with diabetes who use ...References1. Herkert D, Vijayakumar P, Luo J, et al. Cost-related insulin underuse among patients with diabetes. JAMA Intern Med. 2019;179:112-4. [PMID: 30508012] doi:10.1001/jamainternmed.2018.5008 CrossrefMedlineGoogle Scholar2. Pfiester E, Braune K, Thieffry A, et al. Costs and underuse of insulin and diabetes supplies: findings from the 2020 T1International cross-sectional web-based survey. Diabetes Res Clin Pract. 2021;179:108996. [PMID: 34363862] doi:10.1016/j.diabres.2021.108996 CrossrefMedlineGoogle Scholar3. Mulcahy AW, Schwam D, Edenfield N. Comparing Insulin Prices in the United States to Other Countries: Results From a Price Index Analysis. RAND Corporation; 2020. Accessed at www.rand.org/pubs/research_reports/RRA788-1.html on 15 August 2022. Google Scholar4. Biniek JF, Johnson W. Spending on individuals with type 1 diabetes and the role of rapidly increasing insulin prices. Accessed at https://healthcostinstitute.org/diabetes-and-insulin/spending-on-individuals-with-type-1-diabetes-and-the-role-of-rapidly-increasing-insulin-prices on 15 August 2022. Google Scholar5. Randall L, Begovic J, Hudson M, et al. Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors. Diabetes Care. 2011;34:1891-6. [PMID: 21775761] doi:10.2337/dc11-0701 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Adam Gaffney, MD, MPH; David U. Himmelstein, MD; Steffie Woolhandler, MD, MPHAffiliations: Department of Medicine, Cambridge Health Alliance, and Harvard Medical School, Cambridge, MassachusettsHunter College, City University of New York, Department of Medicine, Cambridge Health Alliance, Harvard Medical School, and Public Citizen Health Research Group, New York, New YorkDisclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M22-2477.Reproducible Research Statement:Study protocol: Not available. Statistical code: Available from Dr. Gaffney (e-mail, agaffney@challiance.org). Data set: Available at www.cdc.gov/nchs/nhis/2021nhis.htm.Corresponding Author: Adam Gaffney, MD, MPH, Harvard Medical School/Cambridge Health Alliance, 1493 Cambridge Street, Cambridge, MA 02139; e-mail, agaffney@cha.harvard.edu.This article was published at Annals.org on 18 October 2022. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byEnough Is Enough: On the Road to Eliminating "Sophie's Choice" for U.S. Prescription DrugsDarilyn V. Moyer, MD, and Shari M. Erickson, MPHAssessing—and Extending—California's Insulin Manufacturing InitiativeBringing Environmental Sustainability into the Quality Agenda: Time to Act on Reducing Health Care Pollution and Waste November 2022Volume 175, Issue 11 Page: 1623-1626 Keywords Health economics Insulin Type 1 diabetes Type 2 diabetes ePublished: 18 October 2022 Issue Published: November 2022 Copyright & PermissionsCopyright © 2022 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/m22-2477

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 47

Metadata

Authors
Gaffney, A., Himmelstein, D. U., & Woolhandler, S.
Venue
Annals of Internal Medicine
Published
2022-11
Volume
175
Issue
11
Pages
1623-1626
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W4306662501
Cited by
47
References
2
FWCI
7.70
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence and Correlates of Patient Rationing of Insulin in the United States: A National Survey. https://app.cochat.ai/papers/10.7326/m22-2477
The paper
Gaffney, A., Himmelstein, D. U., & Woolhandler, S. (2022). Prevalence and Correlates of Patient Rationing of Insulin in the United States: A National Survey. Annals of Internal Medicine. https://doi.org/10.7326/m22-2477

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.